A TROP2/Claudin Program Mediates Immune Exclusion to Impede Checkpoint Blockade in Breast Cancer.

Saved in:
Bibliographic Details
Title: A TROP2/Claudin Program Mediates Immune Exclusion to Impede Checkpoint Blockade in Breast Cancer.
Authors: Wu B; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA., Thant W; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA., Bitman E; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA., Liu T; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA., Liu J; Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, 02114, USA., Paschalis EI; Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, 02114, USA., Xu KH; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA., Nieman LT; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA., Ting DT; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA., Thimmiah N; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA., Sun S; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA., Abelman RO; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA., Isakoff SJ; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA., Spring LM; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA., Bardia A; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA., Ellisen LW; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA.; Ludwig Center at Harvard, Boston, MA 02115, USA.
Source: BioRxiv : the preprint server for biology [bioRxiv] 2024 Dec 05. Date of Electronic Publication: 2024 Dec 05.
Publication Type: Journal Article; Preprint
Journal Info: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2692-8205
DOI:10.1101/2024.12.02.626446